4/A//SEC Filing
Ludwig Jeffrey Jerome 4/A
Accession 0001209191-21-013211
CIK 0001401667other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:24 PM ET
Size
5.5 KB
Accession
0001209191-21-013211
Insider Transaction Report
Form 4/AAmended
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
- Award
COMMON STOCK
2021-02-17+36,069→ 36,069 total
Footnotes (1)
- [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to (i) one-third (1/3) of the Restricted Stock Units on the first anniversary of the vesting commencement date of January 1, 2021 (the "Vesting Commencement Date") and (ii) one-sixth (1/6th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001807133
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:24 PM ET
- Size
- 5.5 KB